Citadel Advisors »

Tenax Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Tenax Therapeutics (TENX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Tenax Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenax Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenax Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $329k 43k 7.61
2025-06-30 $60k 10k 5.84
2025-03-31 $152k 23k 6.55

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Tenax Therapeutics

Ikarian Capital
VR Adviser
Rtw Investments
Siren
Boothbay Fund Management
BVF
Millennium Management
Vivo Capital
Morgan Stanley
Marshall Wace
Integral Health Asset Management
Henderson Group
Vanguard Group
Woodline Partners
Adage Capital Partners GP

View all funds holding Tenax Therapeutics